Prokarium is a biotechnology company with a vision to create the best platform for oral delivery of protein vaccines. Our synthetic biology platform Vaxonella makes vaccines more accessible to travellers and people living in rural and resource-poor areas
Prokarium to attend Sachs European Life Sciences CEO Forum
Prokarium will attend Sachs Associates’ European Life Sciences CEO Forum the 3-4 March in Zurich. CEO Ted Fjallman will partake in the vaccines panel discussion chaired by Sanofi Pasteur MSD’s Chris Britten.